Indian Journal of Geo-Marine Sciences

Open Access Open Access  Restricted Access Subscription Access

In-Vitro Biocompatibility Studies of Nanochitosan/Polyvinylpyrrolidone Blends on MC3T3-E1 Cells Showing Beneficial Effect in Bone Tissue Engineering


Affiliations
1 Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu – 600 119, India
2 PG and Research Department of Chemistry, D.K.M College for Women, Vellore, Tamil Nadu – 632 001, India
3 Department of Mechanical Engineering, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu – 600 119, India
 

Chitosan is a naturally occurring polymer with numerous biological properties that can be used in the biomedical field. Chitosan was modified to nanochitosan in this study. The polycationic nature of chitosan interacts with polyanions (TPP) to form nanoparticles. The prepared nanochitosan was mixed with polyvinyl pyrollidone to create binary blends with ratios of 1:1, 1:2, and 2:1. The polymeric blends were interpreted by using the analytical tools FTIR, XRD and SEM. The results of the FTIR and XRD confirm the formation of binary blends with strong electrostatic interaction. The study aims to investigate the compatibility of the prepared blend as tissue regenerative material. The blends were evaluated in-vitro using fluorscent spectroscopy, MTT assay, NRR assay and ALP assay to study its biocompatibility and cell viability. The results revealed that the quick multiplication followed by a moderate increment in cell number of MC3T3-E1 as cells reacted to the prepared material and hence the materials can be used in the regenerative medicine.

Keywords

Cell Viability, MTT Assay, Nanochitosan, PVP.
User
Notifications
Font Size

  • Mohyeldin M S, Soliman E A, Hashem A I & Tamer T M, Antimicrobial activity of novel aminated chitosan derivatives for biomedical applications, J Adv Polym Technol, 31 (2011) 414–428.

  • Tigh R S, Karakecili A & Gumusderelioglu M, In vitro characterization ofchitosan scaffold: influence of compsition and deacetylation degree, J Mater Sci Mater Med, 18 (2007) 1665–1674.

  • Li Q, Wang X, Lou X, Yuan H, Tu H, et al., Genipin-crosslinkedelectrospun chitosan nanofibers: determination of crosslinking conditions and evaluation of cytocompatibility, J Carbohydr Polym, 130 (2015) 166–174.

  • Liu M, Dai L, Shi H, Xiong S & Zhou C, In vitro evaluation of alginate/halloysite nanotube composite scaffold, J Mater Sci Eng C, 49 (2015) 700–712.

  • Zhai R, Zhang B, Wan Y, Li C, Wang J, et al., Chitosan-halloysite hybrid-nanotubes: horseadish peroxidase immobilization and applications in phenol removal, J Chem Eng, 214 (2013) 304–309.

  • Dhiman H K, Ray A R & Panda A K, Characterization and evaluation ofchitosan matrix for in vitro growth of MCF-7 breast cancer cell lines, J Biomater, 25 (2003) 5147–5154

  • Baldino L, Concilio S, Cardea S, De Marco I & Reverchon E, Complete glutaraldehyde elimination during chitosan hydrogel drying by SC-CO2 processing, J Supercrit Fluids, 103 (2015) 70–76.

  • Wenling C, Duohui J, Jiamou L, Yandao G, Nanming Z & Xiufang Z, Effect of the degree of deacetylation on the physicochemical properties andSchwann cell affinity of chitosan films, J Biomater Appl, 20 (2005) 157–177.

  • Godbey W & Atala A, In vitro systems for tissue engineering, Ann Ny Acad Sci, 10 (2002) p. 961.

  • Hadisi Z, Nourmohammadi J & Mohammadi J, Composite of porousstarch-silk fibroin nanofiber-calcium phosphate for bone regeneration, J Ceram Int, 41 (2015) 10745–10754.

  • Lee B H, Lee Y M, Sohn Y S & Song S C, A thermosensitive poly(organophosphazene) gel, Macromolecules, 35 (2002) 3876–3879.

  • Gunatillake P, Mayadunne R & Adhikari R, Recent developments in biodegradable synthetic polymers, Biotechnol Ann Rev, 12 (2006) 301–347.

  • Kim H J, Lee H C, Oh J S, Shin B A, Oh C S, et al., Polyelectrolyte complex composed of chitosan and sodium alginate for wound dressing application, J Biomater Sci, 10 (1999) 543-556

  • Verma A & Pradesh U, Polyelectrolyte complex–and overview, Int J Pharm Sci Res, 4 (2013) 1684-1691.

  • Prabaharan M, Rodriguez-Perez M A, de Saja J A & Mano J F, Preparation and Characterization of Poly(L-lactic acid)-Chitosan Hybrid Scaffolds With Drug Release Capability, J Biomed Mater Res Part B: Appl Biomater, 81B (2007) 427–434.

  • Tanase C E, Popa M I & Verestiuc L, Biomimetic bone scaffolds based on chitosan and calcium phosphates, Mater Lett, 65 (2011) 1681–1683.

  • Yilgor P, Tuzlakoglu K, Reis R, Hasirci N & Hasirci V, Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering, Biomaterials, 30 (2009) 3551–3559.

  • Lee Y M, Park Y J, Lee S J, Ku Y, Han S B, et al., Tissue engineered bone formation using chitosan/tricalcium phosphate sponges, J Periodontol, 71 (2000) 410–417.

  • Lee Y M, Park Y J, Lee S J, Ku Y, Han S B, et al., The bone regenerative effect of platelet-derived growth factor delivered with a chitosan/tricalcium phosphate sponge carrier, J Periodontol, 71 (2000) 418–424.

  • Jayachandran V, Bhatnagar I & Kim S-K, Chitosan-alginate biocomposite containing fucoidan for bone tissue engineering, Mar Drugs, 12 (2014) 300-316.

  • Cascone M G, Barbani N, Cristallini C, Giusti P, Ciardelli G, et al., Bioartificial polymeric materials based on polysaccharides, J Biomater Sci, 12 (2001) 267–281.

  • Adel H, Alkhayatt O, Al-Azzawi A H & Alakayashi Z, Rheological and optical characterization of Polyvinylpyrrolidone (PVP) -Polyethylene glycol (PEG) polymer blends, IOSR J Appl Phys, 8 (2016) 11-18.

  • Mosmann T, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65 (1983) 55–63.

  • Clemedson C & Ekwall B, Overview of the final MEIC results. The in vitro–in vitro evaluation, Toxicol In Vitro, 13 (1999) 657–663.

  • Scheers M E, Ekwall B & Dierickx J P, In vitro long-term cytotoxicity testing of 27 MEIC chemicals on HepG2 cells and comparison with acute human toxicity data, Toxicol In Vitro, 15 (2001) 153–161.

  • Weyermann J, Lochmann D & Zimmer A, A practical note on the use of cytotoxicity assays, Int J Pharm, 288 (2005) 369–376.

  • Seeherman H, Li R & Wozney J, A review of preclinical program development for evaluating injectable carriers for osteogenic factors, J Bone Joint Surg Am, 85A (Suppl 3) (2003) 96–108.

  • Bashir S, Nazir I, Khan H U, Alamgeer, Irfan H M, et al., Invitro Evaluation of Nateglinide-Loaded Microspheres Formulated with Biodegradable Polymers, Trop J Pharm Res, 13 (2014) 1047-1053.

  • Gomathi T, Supriya Prasad P, Sudha P N & Anil S, Size optimization and in vitro biocompatibility studies of chitosan nanoparticles, Int J Biol Macromol, 104 (Part B) (2017) 1794-1806.

  • Tonn J C, Schachenmayr W & Kramer H P, In vitro chemosensitivity test of malignant gliomas: clinical relevance of test results independent of adjuvant chemotherapy, Anticancer Res, 14 (1994) 1371–1375.

  • Raut A R & Khairkar S R, Study of chitosan crosslinked with glutaraldeyde as biocomposite material, World J Pharm Res, 3 (2014) 523-532.

  • Slater T F, Sawyer B & Sträuh U, Studies on succinatetetrazolium reductase system. Ill. Points of coupling of four different tetrazolium salts, Biochim Biophys Acta, 77 (1963) 383-393.

  • Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, et al., Oxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease, Neurobiol Aging, 27 (2006) 262-269.

  • Parish C R & Mullbacher A, Automated colorimetric assay for T cell cytotoxicity, J Immunol Methods, 58 (1983) 223–237.

  • Borenfreund E & Puerner J A, A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR90), J Tissue Cult Methods, 9 (1984) 7–9.

  • Fautz R, Husein B & Hechenberger C, Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: Rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS), Mutat Res, 253 (1991) 173–179.

  • Morgan D C, Mills C K, Lefkowitz L D & Lefkowitz S S, An improved colorimetric assay for tumor necrosis factor using WEHI 164 cells cultured on novel microtiter plates, J Immunol Meth, 145 (1991) 259–262.

  • Griffon G, Marchal C, Merlin J L, Marchal S, Parache R M, et al., Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers, Eur J Cancer, 31A (1995) 85-91.

  • Winckler J, Vital staining of lysosomes and other cell organelles of the rat with neutral Red, Prog Histochem Cytochem, 6 (1974) 1–89.

  • Nemes Z, Dietz R & Luth J B, The pharmacological relevance of vital staining with neutral red, Experientia, 35 (1979) 1475–1476.


Abstract Views: 185

PDF Views: 99




  • In-Vitro Biocompatibility Studies of Nanochitosan/Polyvinylpyrrolidone Blends on MC3T3-E1 Cells Showing Beneficial Effect in Bone Tissue Engineering

Abstract Views: 185  |  PDF Views: 99

Authors

V. Sangeetha
Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu – 600 119, India
P. N. Sudha
PG and Research Department of Chemistry, D.K.M College for Women, Vellore, Tamil Nadu – 632 001, India
J. Jayaprabakar
Department of Mechanical Engineering, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu – 600 119, India

Abstract


Chitosan is a naturally occurring polymer with numerous biological properties that can be used in the biomedical field. Chitosan was modified to nanochitosan in this study. The polycationic nature of chitosan interacts with polyanions (TPP) to form nanoparticles. The prepared nanochitosan was mixed with polyvinyl pyrollidone to create binary blends with ratios of 1:1, 1:2, and 2:1. The polymeric blends were interpreted by using the analytical tools FTIR, XRD and SEM. The results of the FTIR and XRD confirm the formation of binary blends with strong electrostatic interaction. The study aims to investigate the compatibility of the prepared blend as tissue regenerative material. The blends were evaluated in-vitro using fluorscent spectroscopy, MTT assay, NRR assay and ALP assay to study its biocompatibility and cell viability. The results revealed that the quick multiplication followed by a moderate increment in cell number of MC3T3-E1 as cells reacted to the prepared material and hence the materials can be used in the regenerative medicine.

Keywords


Cell Viability, MTT Assay, Nanochitosan, PVP.

References